Hospital Universitari Arnau de Vilanova de Lleida

Lleida, Lerida 25198

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Multiple Sclerosis, Primary Progressive

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed